Abstract 013: Elective Outpatient Middle Meningeal Artery Embolization is Safe and Effective

Chronic subdural hematoma (cSDH) is a common cerebrovascular pathology associated with persistently high rates of morbidity and mortality. Despite transformative advances in clinical medicine and the neurosciences over the past few decades, the cornerstones of cSDH treatment ‐ surgical evacuation or conservative observation ‐ had remained essentially unchanged until recently. Following the results of multiple clinical trials, middle meningeal artery embolization (MMAE) has emerged as a crucial adjunctive therapy that improves outcomes in cSDH. MMAE is well‐tolerated and safe, but how to achieve the best clinical outcomes while reducing resource utilization remains uncertain. We investigated whether elective MMAE performed on an outpatient or inpatient basis affected short‐term health outcomes.

Authors

Institutions

Publication Details

Journal
Stroke Vascular and Interventional Neurology
Published
2024-11-01
DOI
https://doi.org/10.1161/svin.04.suppl_1.013
Primary Topic
Cerebral Venous Sinus Thrombosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 013: Elective Outpatient Middle Meningeal Artery Embolization is Safe and Effective

Zachary A. Abecassis, Karol P. Budohoski, Georgios S. Sioutas, Margaret Louise McGrath et al.
Stroke Vascular and Interventional Neurology
Cerebral Venous Sinus Thrombosis
article

Abstract 013: Elective Outpatient Middle Meningeal Artery Embolization is Safe and Effective

Zachary A. Abecassis, Karol P. Budohoski, Georgios S. Sioutas, Margaret Louise McGrath, Brandon Philbrick, Ramesh Grandhi, Michael R. Levitt, Christopher P. Kellner, José A. Rodríguez, Daniel A. Tonetti, Anthony G. Gallagher, Jan‐Karl Burkhardt, William J. Ares, Spencer L Raub, Kate Carroll
article en

Abstract

Chronic subdural hematoma (cSDH) is a common cerebrovascular pathology associated with persistently high rates of morbidity and mortality. Despite transformative advances in clinical medicine and the neurosciences over the past few decades, the cornerstones of cSDH treatment ‐ surgical evacuation or conservative observation ‐ had remained essentially unchanged until recently. Following the results of multiple clinical trials, middle meningeal artery embolization (MMAE) has emerged as a crucial adjunctive therapy that improves outcomes in cSDH. MMAE is well‐tolerated and safe, but how to achieve the best clinical outcomes while reducing resource utilization remains uncertain. We investigated whether elective MMAE performed on an outpatient or inpatient basis affected short‐term health outcomes.

Stroke Vascular and Interventional NeurologyVol. 4(S1)
Mount Sinai Health System (US), University of Washington (US), University of Utah (US), California University of Pennsylvania (US), Cooper University Health Care (US), Skokie Hospital (US), Indiana University School of Medicine, University of Pennsylvania (US)
Openalex Percentile: Top 61%
Cerebral Venous Sinus Thrombosis
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.